LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
24 ч
Текущая
Мин.
11.4
Макс.
12.03
Доход | 673K -53M |
|---|---|
Продажи | 9.6M 17M |
Прибыль на акцию | -0.32 |
Рентабельность продаж | -308.373 |
Сотрудники | 317 |
EBITDA | 705K -51M |
Рекомендации | Активная покупка |
|---|---|
Прогноз на 12 месяцев | +192.52% upside |
Следующий отчет о доходах | 7 мая 2026 г. |
|---|
Рыночная капитализация | -172M 2.3B |
|---|---|
Предыдущая цена открытия | 12.74 |
Предыдущая цена закрытия | 11.63 |
By Trading Central
Уверенность
Very Strong Bearish Evidence
6.35 / 6.555 Поддержка и Сопротивление
Прошлые результаты не являются надежным индикатором будущих результатов.
23 мар. 2026 г., 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Читать
23 мар. 2026 г., 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Читать
23 мар. 2026 г., 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Читать
23 мар. 2026 г., 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Читать
23 мар. 2026 г., 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Читать
23 мар. 2026 г., 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Читать
23 мар. 2026 г., 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Читать
23 мар. 2026 г., 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Читать
23 мар. 2026 г., 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Читать
23 мар. 2026 г., 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Читать
23 мар. 2026 г., 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Читать
23 мар. 2026 г., 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Читать
23 мар. 2026 г., 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Читать
23 мар. 2026 г., 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Читать
23 мар. 2026 г., 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Читать
23 мар. 2026 г., 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Читать
23 мар. 2026 г., 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Читать
23 мар. 2026 г., 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Читать
23 мар. 2026 г., 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Читать
23 мар. 2026 г., 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Читать
23 мар. 2026 г., 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Читать
23 мар. 2026 г., 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Читать
23 мар. 2026 г., 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Читать
23 мар. 2026 г., 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Читать
23 мар. 2026 г., 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Читать
23 мар. 2026 г., 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Читать
23 мар. 2026 г., 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Читать
23 мар. 2026 г., 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Читать
23 мар. 2026 г., 20:50 UTC
Health Care Roundup: Market Talk
DJ
Читать
23 мар. 2026 г., 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Читать
Изменение цены
By TipRanks
Прогноз на 12 месяцев
Средняя 34.4 USD 192.52%
Максимум 52 USD
Минимум 26 USD
Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для WaVe Life Sciences Ltd на следующие 12 месяцев – Данные за последние 3 месяца.
By TipRanks
Активная покупка
11 ratings
11
Покупка
0
Удержание
0
Продажа
Основано на мнении 11 аналитиков, присваивавших рейтинги акциям WaVe Life Sciences Ltd – Данные за последние 3 месяца.
By Trading Central
Краткосрочная
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Среднесрочная
Bearish Evidence
All events are bearish.
Долгосрочная
Bearish Evidence
Recent bearish events outweigh bullish events.
Расходы на продажи и администрирование
Операционные расходы
Прибыль до уплаты налогов
Продажи
Себестоимость реализации
Валовая прибыль от продаж
Процентные расходы по долгу
EBITDA
Операционная прибыль
$